Cite
MLA Citation
Debra Richardson et al.. “TP037/#453 Up-next (GOG-3049/ENGOT-OV71-NSGO-CTU): a study of upifitamab rilsodotin (UPRI), a NaPi2b -directed antibody drug conjugate (ADC) in platinum-sensitive recurrent ovarian cancer.” International journal of gynecological cancer, vol. 32, n.d., p. A241. http://access.bl.uk/ark:/81055/vdc_100170500953.0x00004c